These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11447687)

  • 21. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammalian prion proteins.
    Jackson GS; Clarke AR
    Curr Opin Struct Biol; 2000 Feb; 10(1):69-74. PubMed ID: 10679460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions and conversions of prion protein isoforms.
    Caughey B; Raymond GJ; Callahan MA; Wong C; Baron GS; Xiong LW
    Adv Protein Chem; 2001; 57():139-69. PubMed ID: 11447689
    [No Abstract]   [Full Text] [Related]  

  • 24. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion protein misfolding.
    Kupfer L; Hinrichs W; Groschup MH
    Curr Mol Med; 2009 Sep; 9(7):826-35. PubMed ID: 19860662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prion proteins meet protein quality control.
    Dimcheff DE; Portis JL; Caughey B
    Trends Cell Biol; 2003 Jul; 13(7):337-40. PubMed ID: 12837603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transmembrane form of the prion protein in neurodegenerative disease.
    Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
    Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A general model of prion strains and their pathogenicity.
    Collinge J; Clarke AR
    Science; 2007 Nov; 318(5852):930-6. PubMed ID: 17991853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
    Horiuchi M; Caughey B
    EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular bases of prion diseases].
    Rać M; Rać M
    Ann Acad Med Stetin; 2006; 52(3):5-13. PubMed ID: 17385343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strain Typing of Prion Diseases Using In Vivo Mouse Models.
    Boyle A; Hogan K; Manson JC; Diack AB
    Methods Mol Biol; 2017; 1658():263-283. PubMed ID: 28861795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion diseases and the BSE crisis.
    Prusiner SB
    Science; 1997 Oct; 278(5336):245-51. PubMed ID: 9323196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spongiform encephalopathies. Tracking turncoat prion proteins.
    Masters CL; Beyreuther K
    Nature; 1997 Jul; 388(6639):228-9. PubMed ID: 9230425
    [No Abstract]   [Full Text] [Related]  

  • 35. Transmissible spongiform encephalopathies and prion protein interconversions.
    Caughey B; Chesebro B
    Adv Virus Res; 2001; 56():277-311. PubMed ID: 11450303
    [No Abstract]   [Full Text] [Related]  

  • 36. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases.
    Rossetti G; Cong X; Caliandro R; Legname G; Carloni P
    J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular pathogenesis of spongiform encephalopathy].
    Aguzzi A; Maddalena A; Brandner S; Klein M
    Pathologica; 1997 Oct; 89(5):481-90. PubMed ID: 9489393
    [No Abstract]   [Full Text] [Related]  

  • 38. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
    Weissmann C
    FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generating a prion with bacterially expressed recombinant prion protein.
    Wang F; Wang X; Yuan CG; Ma J
    Science; 2010 Feb; 327(5969):1132-5. PubMed ID: 20110469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell culture models of transmissible spongiform encephalopathies.
    Béranger F; Mangé A; Solassol J; Lehmann S
    Biochem Biophys Res Commun; 2001 Nov; 289(2):311-6. PubMed ID: 11716473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.